A company developing and manufacturing advanced wearable infusion devices has entered into a multi-product development agreement with insulin supplier Sanofi.
Developed and manufactured by Enable Injections, the enFuse is an on-body device which allows people to self-administer subcutaneous delivery of high-volume medicines and has the potential to give people an alternative method of delivering insulin and other therapies.
Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
